UnitedHealth is up 24.3% YTD and still screens cheap at 23.6x earnings versus a 25.7x sector average and 29.7x peer group. It raised 2026 adjusted EPS guidance after stronger Q3, so the debate is how

What happened: UnitedHealth Group ($UNH) is up 24.3% year to date after raising its 2026 adjusted EPS outlook following stronger Q3 results, prompting questions about whether the stock remains a bargain. Key numbers: $UNH up 24.3% YTD. P/E of 23.6x versus Healthcare sector average of 25.7x and peer group near 29.7x. Why it matters: The P/E screens as undervalued on the Fair Ratio framework, suggesting the upbeat guidance has not fully closed the gap implied by that earnings based yardstick. Community views split between AI driven efficiency and regulatory and integration risk. Market: -1.6% today ($418.09), +25.2% YTD, 0.7x vol — as of 22:46 UTC

UnitedHealth Group ($UNH) is up 24.3% year to date after raising its 2026 adjusted EPS outlook following stronger Q3 results, prompting questions about whether the stock remains a bargain.

The P/E screens as undervalued on the Fair Ratio framework, suggesting the upbeat guidance has not fully closed the gap implied by that earnings based yardstick. Community views split between AI driven efficiency and regulatory and integration risk. Market: -1.6% today ($418.09), +25.2% YTD, 0.7x vol — as of 22:46 UTC